Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults
Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (49)
- Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use. 2026-01-01 · Expand citations
- Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use. 2026-01-01 · Expand citations
- Magic of the Mushrooms: Effects of Psilocybin Decriminalization. 2025-01-01 · Expand citations
- Psychedelic Microdosing among Young Adults from Southern California. 2025-01-01 · Expand citations
- Less is more? A review of psilocybin microdosing. 2024-10-01 · Expand citations
- Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. 2024-03-01 · Expand citations
- The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. 2023-09-01 · Expand citations
- Microdosing psilocybin for chronic pain: a case series. 2023-04-01 · Expand citations
- Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
- Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids. 2022-11-15 · Expand citations
- Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. 2022-08-02 · Expand citations
- Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. 2022-01-01 · Expand citations
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. 2022-01-01 · Expand citations
- Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. 2021-11-18 · Expand citations
- Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. 2020-12-01 · Expand citations
- Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. 2020-06-01 · Expand citations
- Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. 2020-05-01 · Expand citations
- Psychedelics and Psychedelic-Assisted Psychotherapy. 2020-05-01 · Expand citations
- Microdosing psychedelics: Motivations, subjective effects and harm reduction. 2020-01-01 · Expand citations
- Psychedelic Microdosing: A Subreddit Analysis. 2020-01-01 · Expand citations
- Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. 2019-09-01 · Expand citations
- Psychedelic microdosing benefits and challenges: an empirical codebook. 2019-07-10 · Expand citations
- Motives and Side-Effects of Microdosing With Psychedelics Among Users. 2019-07-01 · Expand citations
- Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers. 2019-01-01 · Expand citations
- 10.1001/jama.2015.6358
- 10.1001/jamahealthforum.2024.1653
- 10.1001/jamanetworkopen.2021.10918
- 10.1001/jamanetworkopen.2023.28691
- 10.1001/jamapsychiatry.2025.0044
- 10.1007/s00213-020-05703-9
- 10.1007/s11136-014-0726-4
- 10.1007/s11606-022-07957-9
- 10.1016/j.amepre.2019.06.017
- 10.1016/j.amepre.2021.09.016
- 10.1016/j.amepre.2024.05.006
- 10.1016/j.amepre.2025.108026
- 10.1016/j.socscimed.2024.116702
- 10.1016/s0140-6736(19)31789-1
- 10.1038/s41598-025-03873-0
- 10.1080/02791072.2020.1718250
- 10.1080/02791072.2024.2304554
- 10.1089/can.2023.0084
- 10.1136/bmjopen-2019-035148
- 10.1177/0269881120940937
- 10.1177/13872877251389608
- 10.1186/s42238-025-00359-8
- 10.2196/36667
- 10.3389/fpubh.2026.1720348
- 10.3390/businesses1030014